<?xml version="1.0" encoding="UTF-8"?>
<p id="Par7">Our national response to HIV/AIDS has shown us that in addition to funding the biomedical enterprise so that it can deliver effective treatments (including an eventual vaccine), we must also invest in a strong, stable public health system that is ready to respond when calamities like COVID-19 hit [
 <xref ref-type="bibr" rid="CR17">17</xref>]. Addressing chronic underfunding in state and local health departments is key to that effort [
 <xref ref-type="bibr" rid="CR18">18</xref>, 
 <xref ref-type="bibr" rid="CR19">19</xref>]. Nor should we ignore the vital role that non-governmental organizations—especially community-based organizations—can play when they work in partnership with public health agencies. In the United States and across the world, NGOs have been a critical component in successful efforts to prevent and treat HIV [
 <xref ref-type="bibr" rid="CR20">20</xref>]. And adequately funded HIV surveillance systems in the U.S.—a rarity among other infectious diseases like hepatitis C virus (HCV)—have provided increasingly detailed information that enable us to quickly identify emerging outbreaks and accurately target prevention and care services to underserved areas.
</p>
